135 related articles for article (PubMed ID: 22996376)
1. Thymidylate synthase expression and molecular alterations in adenosquamous carcinoma of the lung.
Shu C; Cheng H; Wang A; Mansukhani MM; Powell CA; Halmos B; Borczuk AC
Mod Pathol; 2013 Feb; 26(2):239-46. PubMed ID: 22996376
[TBL] [Abstract][Full Text] [Related]
2. Adenosquamous carcinoma of the lung: a microdissection study of KRAS and EGFR mutational and amplification status in a western patient population.
Tochigi N; Dacic S; Nikiforova M; Cieply KM; Yousem SA
Am J Clin Pathol; 2011 May; 135(5):783-9. PubMed ID: 21502435
[TBL] [Abstract][Full Text] [Related]
3. Analysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomas.
Wang R; Pan Y; Li C; Zhang H; Garfield D; Li Y; Ye T; Hu H; Luo X; Li H; Zhang Y; Zhang J; Zhou X; Shen L; Pao W; Sun Y; Chen H
J Thorac Oncol; 2014 Jun; 9(6):760-8. PubMed ID: 24481316
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of lung adenosquamous carcinoma: hybrid or genuine type?
Vassella E; Langsch S; Dettmer MS; Schlup C; Neuenschwander M; Frattini M; Gugger M; Schäfer SC
Oncotarget; 2015 Sep; 6(27):23905-16. PubMed ID: 26068980
[TBL] [Abstract][Full Text] [Related]
5. High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.
Nunez MI; Behrens C; Woods DM; Lin H; Suraokar M; Kadara H; Hofstetter W; Kalhor N; Lee JJ; Franklin W; Stewart DJ; Wistuba II
J Thorac Oncol; 2012 May; 7(5):833-40. PubMed ID: 22729036
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Pemetrexed-Based Chemotherapy in Patients with ROS1 Fusion-Positive Lung Adenocarcinoma Compared with in Patients Harboring Other Driver Mutations in East Asian Populations.
Chen YF; Hsieh MS; Wu SG; Chang YL; Yu CJ; Yang JC; Yang PC; Shih JY
J Thorac Oncol; 2016 Jul; 11(7):1140-52. PubMed ID: 27094798
[TBL] [Abstract][Full Text] [Related]
7. Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma.
Brody JR; Costantino CL; Potoczek M; Cozzitorto J; McCue P; Yeo CJ; Hruban RH; Witkiewicz AK
Mod Pathol; 2009 May; 22(5):651-9. PubMed ID: 19270646
[TBL] [Abstract][Full Text] [Related]
8. EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung.
Jia XL; Chen G
Lung Cancer; 2011 Dec; 74(3):396-400. PubMed ID: 21592614
[TBL] [Abstract][Full Text] [Related]
9. Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: a case report.
Rossing HH; Grauslund M; Urbanska EM; Melchior LC; Rask CK; Costa JC; Skov BG; Sørensen JB; Santoni-Rugiu E
BMC Res Notes; 2013 Nov; 6():489. PubMed ID: 24279718
[TBL] [Abstract][Full Text] [Related]
10. Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung.
Kang SM; Kang HJ; Shin JH; Kim H; Shin DH; Kim SK; Kim JH; Chung KY; Kim SK; Chang J
Cancer; 2007 Feb; 109(3):581-7. PubMed ID: 17186532
[TBL] [Abstract][Full Text] [Related]
11. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.
Shaozhang Z; Xiaomei L; Aiping Z; Jianbo H; Xiangqun S; Qitao Y
Genes Chromosomes Cancer; 2012 Oct; 51(10):925-32. PubMed ID: 22736493
[TBL] [Abstract][Full Text] [Related]
12. Transition from squamous cell carcinoma to adenocarcinoma in adenosquamous carcinoma of the lung.
Kanazawa H; Ebina M; Ino-Oka N; Shimizukawa M; Takahashi T; Fujimura S; Imai T; Nukiwa T
Am J Pathol; 2000 Apr; 156(4):1289-98. PubMed ID: 10751354
[TBL] [Abstract][Full Text] [Related]
13. Expression of phosphatase and tensin homolog and programmed cell death ligand 1 in adenosquamous carcinoma of the lung.
Hlaing AM; Furusato B; Udo E; Kitamura Y; Souda M; Masutani M; Fukuoka J
Biochem Biophys Res Commun; 2018 Sep; 503(4):2764-2769. PubMed ID: 30100056
[TBL] [Abstract][Full Text] [Related]
14. Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers.
Onozato R; Kosaka T; Kuwano H; Sekido Y; Yatabe Y; Mitsudomi T
J Thorac Oncol; 2009 Jan; 4(1):5-11. PubMed ID: 19096300
[TBL] [Abstract][Full Text] [Related]
15. Mutations of EGFR or KRAS and expression of chemotherapy-related genes based on small biopsy samples in stage IIIB and IV inoperable non-small cell lung cancer.
Deng LL; Deng HB; Lu CL; Guo Y; Wang D; Yan CH; Lv X; Shao YX
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2097-105. PubMed ID: 24994038
[TBL] [Abstract][Full Text] [Related]
16. Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins.
Vatan O; Bilaloglu R; Tunca B; Cecener G; Gebitekin C; Egeli U; Yakut T; Urer N
Tumori; 2007; 93(5):473-7. PubMed ID: 18038880
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features and outcomes of patients with lung adenocarcinomas harboring BRAF mutations in the Lung Cancer Mutation Consortium.
Villaruz LC; Socinski MA; Abberbock S; Berry LD; Johnson BE; Kwiatkowski DJ; Iafrate AJ; Varella-Garcia M; Franklin WA; Camidge DR; Sequist LV; Haura EB; Ladanyi M; Kurland BF; Kugler K; Minna JD; Bunn PA; Kris MG
Cancer; 2015 Feb; 121(3):448-56. PubMed ID: 25273224
[TBL] [Abstract][Full Text] [Related]
18. ALK-rearranged lung cancer: adenosquamous lung cancer masquerading as pure squamous carcinoma.
Chaft JE; Rekhtman N; Ladanyi M; Riely GJ
J Thorac Oncol; 2012 Apr; 7(4):768-9. PubMed ID: 22425930
[No Abstract] [Full Text] [Related]
19. Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer.
Dorff TB; Schuckman AK; Schwartz R; Rashad S; Bulbul A; Cai J; Pinski J; Ma Y; Danenberg K; Skinner E; Quinn DI
Clin Genitourin Cancer; 2016 Oct; 14(5):450-456.e1. PubMed ID: 26935231
[TBL] [Abstract][Full Text] [Related]
20. Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?
Bastide K; Ugolin N; Levalois C; Bernaudin JF; Chevillard S
Lung Cancer; 2010 Apr; 68(1):1-9. PubMed ID: 20004040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
